Page last updated: 2024-08-24

glucuronic acid and glucagon-like peptide 1

glucuronic acid has been researched along with glucagon-like peptide 1 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishimoto, K; Shima, K; Suda, T; Yoshimoto, S1
Brinker, T; Geigle, P; Harmening, K; Heile, A; Klinge, PM; Miller, MC; Wallrapp, C1
de Jong, R; den Dekker, WK; Duckers, HJ; Hoefer, I; Houtgraaf, JH; Kazemi, K; Lewis, AL; Monkhorst, K; Pasterkamp, G; Stratford, PW; Tempel, D; van de Kamp, E; Wallrapp, C; Zijlstra, F1
Geigle, P; Jork, A; Kassem, M; Thoenes, E; Thürmer, F; Wallrapp, C1
Farrell, KA; Holt, CM; Kassem, M; Lewis, AL; Malik, N; Wallrapp, C; Wright, EJ1

Other Studies

5 other study(ies) available for glucuronic acid and glucagon-like peptide 1

ArticleYear
Relationship between molecular structures of sugars and their ability to stimulate the release of glucagon-like peptide-1 from canine ileal loops.
    Acta endocrinologica, 1990, Volume: 123, Issue:4

    Topics: 3-O-Methylglucose; Animals; Carbohydrates; Dogs; Female; Galactose; Glucagon-Like Peptide 1; Glucose; Glucuronates; Glucuronic Acid; Ileum; Kinetics; Male; Maltose; Mesenteric Veins; Methylglucosides; Peptides; Structure-Activity Relationship; Sucrose; Sugar Alcohols

1990
Encapsulated native and glucagon-like peptide-1 transfected human mesenchymal stem cells in a transgenic mouse model of Alzheimer's disease.
    Neuroscience letters, 2011, Jun-15, Volume: 497, Issue:1

    Topics: Alginates; Alzheimer Disease; Amyloid beta-Peptides; Animals; Biocompatible Materials; Capsules; Cell Line; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Genetic Therapy; Glucagon-Like Peptide 1; Glucuronic Acid; Hexuronic Acids; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Transgenic; Transfection

2011
Feasibility of intracoronary GLP-1 eluting CellBead™ infusion in acute myocardial infarction.
    Cell transplantation, 2013, Volume: 22, Issue:3

    Topics: Acute Disease; Alginates; Animals; Apoptosis; Balloon Occlusion; Cell- and Tissue-Based Therapy; Female; Glucagon-Like Peptide 1; Glucuronic Acid; Hexuronic Acids; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Pilot Projects; Swine

2013
Cell-based delivery of glucagon-like peptide-1 using encapsulated mesenchymal stem cells.
    Journal of microencapsulation, 2013, Volume: 30, Issue:4

    Topics: Alginates; Animals; Cell Line, Tumor; Cells, Immobilized; Drug Carriers; Endothelial Growth Factors; Glucagon-Like Peptide 1; Glucuronic Acid; Hexuronic Acids; Humans; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neurotrophin 3; Recombinant Proteins

2013
Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a beneficial effect on failing pig hearts.
    Stem cells translational medicine, 2012, Volume: 1, Issue:10

    Topics: Alginates; Anatomy, Cross-Sectional; Animals; Apoptosis; Cardiotonic Agents; Cell Survival; Disease Models, Animal; Drug Delivery Systems; Echocardiography; Glucagon-Like Peptide 1; Glucuronic Acid; Heart Failure; Hexuronic Acids; Humans; In Situ Nick-End Labeling; Inflammation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myofibroblasts; Neovascularization, Pathologic; Recombinant Fusion Proteins; Sus scrofa; Ventricular Function, Left

2012